The clinical guideline provides recommendations for the management of patients with acute coronary syndromes (ACS). It outlines the importance of prompt diagnosis, risk stratification, and appropriate treatment strategies for patients presenting with ACS. The guideline emphasizes the use of evidence-based therapies such as antiplatelet agents, beta-blockers, statins, and reperfusion therapy for patients with ST-segment elevation myocardial infarction (STEMI). It also highlights the importance of lifestyle modifications, cardiac rehabilitation, and long-term secondary prevention measures to reduce the risk of recurrent cardiovascular events. Overall, the guideline aims to improve outcomes and quality of care for patients with ACS.